These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 8395505
1. Introduction of lysine and clot binding properties in the kringle one domain of tissue-type plasminogen activator. Bakker AH, van der Greef W, Rehberg EF, Marotti KR, Verheijen JH. J Biol Chem; 1993 Sep 05; 268(25):18496-501. PubMed ID: 8395505 [Abstract] [Full Text] [Related]
2. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator. Bakker AH, Nieuwenbroek NM, Verheijen JH. Protein Eng; 1995 Dec 05; 8(12):1295-1302. PubMed ID: 8869642 [Abstract] [Full Text] [Related]
3. Involvement of aspartic and glutamic residues in kringle-2 of tissue-type plasminogen activator in lysine binding, fibrin binding and stimulation of activity as revealed by chemical modification and oligonucleotide-directed mutagenesis. Weening-Verhoeff EJ, Quax PH, van Leeuwen RT, Rehberg EF, Marotti KR, Verheijen JH. Protein Eng; 1990 Dec 05; 4(2):191-8. PubMed ID: 1963688 [Abstract] [Full Text] [Related]
4. Biochemical and functional characterization of human tissue-type plasminogen activator variants obtained by deletion and/or duplication of structural/functional domains. Lijnen HR, Nelles L, Van Hoef B, De Cock F, Collen D. J Biol Chem; 1990 Apr 05; 265(10):5677-83. PubMed ID: 2156824 [Abstract] [Full Text] [Related]
5. On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin. Inhibition of kringle-2 binding to fibrin by epsilon-amino caproic acid. van Zonneveld AJ, Veerman H, Pannekoek H. J Biol Chem; 1986 Oct 25; 261(30):14214-8. PubMed ID: 3021732 [Abstract] [Full Text] [Related]
6. Biochemical and functional characterization of human tissue-type plasminogen activator variants with mutagenized kringle domains. Collen D, Lijnen HR, Bulens F, Vandamme AM, Tulinsky A, Nelles L. J Biol Chem; 1990 Jul 25; 265(21):12184-91. PubMed ID: 2115513 [Abstract] [Full Text] [Related]
7. Study of tissue-type plasminogen activator binding sites on fibrin using distinct fragments of fibrinogen. Grailhe P, Nieuwenhuizen W, Anglés-Cano E. Eur J Biochem; 1994 Feb 01; 219(3):961-7. PubMed ID: 8112348 [Abstract] [Full Text] [Related]
8. Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA). Nelles L, Lijnen HR, Van Nuffelen A, Demarsin E, Collen D. Thromb Haemost; 1990 Aug 13; 64(1):53-60. PubMed ID: 2148847 [Abstract] [Full Text] [Related]
9. The position of the structurally autonomous kringle 2 domain influences the functional features of tissue-type plasminogen activator. Bakker AH, Rehberg EF, Marotti KR, Verheijen JH. Protein Eng; 1995 Mar 13; 8(3):293-300. PubMed ID: 7479691 [Abstract] [Full Text] [Related]
10. Kringle glycosylation in a modified human tissue plasminogen activator improves functional properties. Berg DT, Burck PJ, Berg DH, Grinnell BW. Blood; 1993 Mar 01; 81(5):1312-22. PubMed ID: 8382971 [Abstract] [Full Text] [Related]
11. Regulation of fibrinolysis by C-terminal lysines operates through plasminogen and plasmin but not tissue-type plasminogen activator. Silva MM, Thelwell C, Williams SC, Longstaff C. J Thromb Haemost; 2012 Nov 01; 10(11):2354-60. PubMed ID: 22974122 [Abstract] [Full Text] [Related]
13. Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E. Stewart RJ, Fredenburgh JC, Weitz JI. J Biol Chem; 1998 Jul 17; 273(29):18292-9. PubMed ID: 9660794 [Abstract] [Full Text] [Related]
14. Tissue-type plasminogen activator and its substrate Glu-plasminogen share common binding sites in limited plasmin-digested fibrin. de Vries C, Veerman H, Koornneef E, Pannekoek H. J Biol Chem; 1990 Aug 15; 265(23):13547-52. PubMed ID: 2143185 [Abstract] [Full Text] [Related]
15. Functional characterization of monoclonal antibodies directed against fibrin binding domains of tissue-type plasminogen activator. Wojta J, Beckmann R, Turcu L, Wagner OF, van Zonneveld AJ, Binder BR. J Biol Chem; 1989 May 15; 264(14):7957-61. PubMed ID: 2470738 [Abstract] [Full Text] [Related]
16. Binding of tissue-type plasminogen activator to lysine, lysine analogues, and fibrin fragments. de Munk GA, Caspers MP, Chang GT, Pouwels PH, Enger-Valk BE, Verheijen JH. Biochemistry; 1989 Sep 05; 28(18):7318-25. PubMed ID: 2510823 [Abstract] [Full Text] [Related]
17. Functional properties of the recombinant kringle-2 domain of tissue plasminogen activator produced in Escherichia coli. Wilhelm OG, Jaskunas SR, Vlahos CJ, Bang NU. J Biol Chem; 1990 Aug 25; 265(24):14606-11. PubMed ID: 2117612 [Abstract] [Full Text] [Related]
18. The role of the lysyl binding site of tissue-type plasminogen activator in the interaction with a forming fibrin clot. Bakker AH, Weening-Verhoeff EJ, Verheijen JH. J Biol Chem; 1995 May 26; 270(21):12355-60. PubMed ID: 7759476 [Abstract] [Full Text] [Related]